Vascular endothelial growth factor A inhibition remodels the transcriptional signature of lipid metabolism in psoriasis non‐lesional skin in 12 h ex vivo culture
Abstract Background Vascular endothelial growth factor A (VEGF‐A)‐mediated angiogenesis is involved in the pathogenesis of psoriasis. VEGF‐A inhibitors are widely used to treat oncological and ophthalmological diseases but have not been used in psoriasis management. The molecular mechanisms underlyi...
Saved in:
Main Authors: | Andrea Luengas‐Martinez (Author), Dina Ismail (Author), Ralf Paus (Author), Helen S. Young (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of vascular endothelial growth factor‐A downregulates angiogenesis in psoriasis: A pilot study
by: Andrea Luengas‐Martinez, et al.
Published: (2023) -
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
by: Weidemann AK, et al.
Published: (2013) -
Global Transcriptional Profiling Reveals Novel Autocrine Functions of Interleukin 6 in Human Vascular Endothelial Cells
by: Liza U. Ljungberg, et al.
Published: (2020) -
Transcription Factors Involved in the Development and Prognosis of Cardiac Remodeling
by: Jia-Hui Hong, et al.
Published: (2022) -
Apremilast Improves Endothelial Glycocalyx Integrity, Vascular and Left Ventricular Myocardial Function in Psoriasis
by: Ignatios Ikonomidis, et al.
Published: (2022)